AAL

Novavax Stock on Track for Worst Day Since 2022

The company's fourth-quarter results missed expectations

Digital Content Manager
Feb 28, 2024 at 10:44 AM
facebook X logo linkedin


Novavax Inc (NASDAQ:NVAX) missed top- and bottom-line estimates for the fourth quarter. The company noted its plans to cut costs, and still narrowed losses from the fourth quarter despite slowing Covid-19 vaccine demand. NVAX is down 26.3% to trade at $4.43 at last check.

The shares have struggled to stay above penny stock territory, while their 200-day moving average has acted as long-term pressure. If these losses hold, NVAX could mark its worst daily percentage loss since December 2022. In the past 12 months, the security dropped over 52%.

Options traders are chiming in, with 26,000 calls and 11,000 puts exchanged so far, which is seven times the intraday average volume. Most active is the weekly 3/1 4-strike put, with new positions opening there.

The security's 50-day call/put volume ratio of 3.96 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) sits higher than 86% of readings from the past year. This suggests options traders have been more bullish than usual in the last 10 weeks.

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.